Tomeglovir

CAS : 233254-24-5

Ref. 3D-IJA25424

Informations sur le produit

• Nom: Tomeglovir
• Synonymes: Bay-38-4766, N-[4-({[5-(dimethylamino)naphthalen-1-yl]sulfonyl}amino)phenyl]-3-hydroxy-2,2-dimethylpropanamide

Description

Tomeglovir is a monoclonal antibody that has been designed to target the enzyme non-nucleoside polymerase. This drug is an oral prodrug that has been developed for the treatment of hepatitis B and C, as well as herpes simplex virus and influenza virus. Tomeglovir inhibits the RNA-dependent DNA polymerase of these viruses, which prevents them from replicating in cells. Tomeglovir also binds to human T-cell leukemia virus type 1 (HTLV-1) and blocks its reverse transcriptase, inhibiting viral replication. Tomeglovir is in phase II clinical trials for cancer and hepatitis C.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 441.54 g/mol
• Formule: C₂₃H₂₇N₃O₄S
• Degré de pureté: Min. 95%